X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18715) 18715
Government Document (205) 205
Book Chapter (134) 134
Dissertation (128) 128
Magazine Article (39) 39
Publication (33) 33
Conference Proceeding (16) 16
Book / eBook (8) 8
Web Resource (7) 7
Newspaper Article (5) 5
Journal / eJournal (2) 2
Streaming Video (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13920) 13920
female (11031) 11031
brca1 (8711) 8711
oncology (7364) 7364
breast cancer (7209) 7209
breast neoplasms - genetics (7154) 7154
mutation (6000) 6000
genes, brca1 (5172) 5172
middle aged (4984) 4984
adult (4876) 4876
cancer (4457) 4457
brca1 protein - genetics (4230) 4230
ovarian neoplasms - genetics (3519) 3519
genes, brca2 (3329) 3329
genetic aspects (3225) 3225
genetic predisposition to disease (3144) 3144
ovarian cancer (3134) 3134
aged (3118) 3118
ovarian-cancer (2872) 2872
women (2809) 2809
genetics & heredity (2804) 2804
risk factors (2775) 2775
brca1 protein (2613) 2613
risk (2597) 2597
brca2 (2502) 2502
breast-cancer (2251) 2251
research (2184) 2184
brca2 protein - genetics (2086) 2086
genes (2083) 2083
male (2077) 2077
mutations (2064) 2064
animals (1924) 1924
genetic testing (1871) 1871
dna repair (1812) 1812
biochemistry & molecular biology (1802) 1802
breast neoplasms - pathology (1779) 1779
brca1 protein - metabolism (1736) 1736
brca2 protein (1667) 1667
cell biology (1608) 1608
dna damage (1559) 1559
tumors (1503) 1503
genetics (1500) 1500
skin and connective tissue diseases (1462) 1462
health aspects (1461) 1461
germ-line mutation (1407) 1407
gene mutations (1395) 1395
breast (1350) 1350
expression (1313) 1313
prognosis (1303) 1303
gene (1271) 1271
analysis (1248) 1248
proteins (1213) 1213
mice (1170) 1170
breast neoplasms - epidemiology (1153) 1153
heterozygote (1149) 1149
gene expression (1129) 1129
cell line, tumor (1121) 1121
susceptibility (1118) 1118
deoxyribonucleic acid--dna (1105) 1105
breast neoplasms - diagnosis (1097) 1097
dna (1090) 1090
aged, 80 and over (1088) 1088
homologous recombination (1079) 1079
genetic counseling (1067) 1067
medicine & public health (1024) 1024
obstetrics & gynecology (1016) 1016
survival (1003) 1003
breast neoplasms - metabolism (991) 991
risk assessment (990) 990
chemotherapy (984) 984
pedigree (975) 975
germline mutations (958) 958
endocrine system diseases (948) 948
neoplasm proteins - genetics (940) 940
repair (938) 938
carriers (917) 917
surgery (916) 916
diagnosis (905) 905
families (903) 903
genetic screening (903) 903
breast neoplasms - prevention & control (901) 901
transcription factors - genetics (882) 882
care and treatment (875) 875
carcinoma (869) 869
dna mutational analysis (833) 833
genetic research (824) 824
protein (816) 816
prevalence (797) 797
gene expression regulation, neoplastic (776) 776
case-control studies (775) 775
cells (771) 771
ovarian neoplasms - pathology (770) 770
research article (765) 765
multidisciplinary sciences (763) 763
oncology, experimental (761) 761
phosphorylation (750) 750
hereditary breast (722) 722
epidemiology (721) 721
pathology (713) 713
young adult (703) 703
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18119) 18119
Chinese (379) 379
French (284) 284
German (119) 119
Japanese (109) 109
Russian (80) 80
Spanish (70) 70
Polish (59) 59
Czech (47) 47
Korean (27) 27
Portuguese (17) 17
Dutch (13) 13
Italian (11) 11
Hungarian (9) 9
Persian (9) 9
Bulgarian (8) 8
Hebrew (8) 8
Swedish (8) 8
Croatian (5) 5
Danish (5) 5
Norwegian (5) 5
Finnish (2) 2
Lithuanian (2) 2
Serbian (2) 2
Slovak (2) 2
Turkish (2) 2
Breton (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human mutation, ISSN 1059-7794, 11/2012, Volume 33, Issue 11, pp. 1526 - 1537
Journal Article
Nature cell biology, ISSN 1476-4679, 2018, Volume 20, Issue 8, pp. 954 - 965
BRCA1 deficiencies cause breast, ovarian, prostate and other cancers, and render tumours hypersensitive to poly(ADP-ribose) polymerase (PARP) inhibitors. To... 
PATHWAY CHOICE | STRAND BREAK REPAIR | RESECTION | DAMAGE-RESPONSE | 53BP1 | CLASS-SWITCH RECOMBINATION | FANCONI-ANEMIA | DIFFERENTIAL EXPRESSION ANALYSIS | POLYMERASE-ZETA | TELOMERES | CELL BIOLOGY | Osteosarcoma - drug therapy | Mad2 Proteins - metabolism | Humans | Multiprotein Complexes | Ovarian Neoplasms - pathology | Bone Neoplasms - pathology | DNA Breaks, Double-Stranded | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Ovarian Neoplasms - genetics | Telomere-Binding Proteins - genetics | DNA End-Joining Repair | HEK293 Cells | Female | Bone Neoplasms - genetics | Ovarian Neoplasms - metabolism | Bone Neoplasms - drug therapy | BRCA1 Protein - deficiency | Telomere-Binding Proteins - metabolism | Ovarian Neoplasms - drug therapy | Osteosarcoma - metabolism | DNA-Binding Proteins | Tumor Suppressor p53-Binding Protein 1 - metabolism | Recombinational DNA Repair | Tumor Suppressor p53-Binding Protein 1 - genetics | Cisplatin - pharmacology | Breast Neoplasms - drug therapy | Proteins - genetics | Xenograft Model Antitumor Assays | BRCA1 Protein - genetics | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Proteins - metabolism | Breast Neoplasms - pathology | Mad2 Proteins - genetics | Cell Line, Tumor | Mice | Osteosarcoma - genetics | Cell Cycle Proteins | Osteosarcoma - pathology | Care and treatment | DNA | Cancer cells | Breast cancer | Genetic aspects | Research | Gene expression | Single-stranded DNA | DNA damage | Homologous recombination | Poly(ADP-ribose) | Homology | Genomes | Inactivation | Proteins | Ribose | Null cells | Deoxyribonucleic acid--DNA | BRCA2 protein | CRISPR | Deactivation | BRCA1 protein | Poly(ADP-ribose) polymerase | Adenosine diphosphate | Oligosaccharides | Double-strand break repair | Screens | Cisplatin | Polymerase | Inhibitors | Prostate | Viability | Tumors | Telomere-Binding Proteins / metabolism | Osteosarcoma / genetics | Telomere-Binding Proteins / genetics | BRCA1 Protein / genetics | Cellular Biology | Genetics | Proteins / genetics | Osteosarcoma / drug therapy | Ovarian Neoplasms / genetics | Mad2 Proteins / genetics | Proteins / metabolism | Breast Neoplasms / drug therapy | Breast Neoplasms / metabolism | Tumor Suppressor p53-Binding Protein 1 / genetics | BRCA1 Protein / deficiency | Ovarian Neoplasms / metabolism | Mad2 Proteins / metabolism | Breast Neoplasms / pathology | Bone Neoplasms / genetics | Ovarian Neoplasms / pathology | Bone Neoplasms / pathology | Life Sciences | Bone Neoplasms / drug therapy | Ovarian Neoplasms / drug therapy | Osteosarcoma / metabolism | Biochemistry, Molecular Biology | Breast Neoplasms / genetics | Drug Resistance, Neoplasm / genetics | Osteosarcoma / pathology | Bone Neoplasms / metabolism | Poly(ADP-ribose) Polymerase Inhibitors / pharmacology | Cisplatin / pharmacology | Molecular biology | Tumor Suppressor p53-Binding Protein 1 / metabolism | Cancer
Journal Article
Journal Article
Journal Article
Familial Cancer, ISSN 1389-9600, 1/2019, Volume 18, Issue 1, pp. 29 - 35
Journal Article
Journal Article
Nature (London), ISSN 0028-0836, 2019, Volume 571, Issue 7766, pp. 521 - 521
Journal Article
Journal Article